https://www.australianhealthcareherald.com/article/904615111-aexa-aerospace-and-spaceport-australia-work-together-to-create-the-world-s-first-deductive-medical-ai Australian Healthcare Herald en PressRelease 2026-04-27T20:00:00+00:00 Aexa Aerospace® and SpacePort Australia® Work together to create the world’s first deductive medical AI https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829058-space-exploration-and-ai-hologr-2048x1536.jpeg https://www.australianhealthcareherald.com/article/908584685-educational-webinar-unlocking-the-potential-of-psma-therapy-a-next-generation-portfolio-approach Australian Healthcare Herald en PressRelease 2026-04-27T23:27:05+00:00 Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.australianhealthcareherald.com/article/908349860-rezibase-launches-australia-s-leading-respiratory-and-sleep-lab-platform-in-the-uk-at-artp-2026 Australian Healthcare Herald en PressRelease 2026-04-27T04:37:48+00:00 Rezibase Launches Australia's Leading Respiratory and Sleep Lab Platform in the UK at ARTP 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24806393-rezibase-software-2566x1181.png https://www.australianhealthcareherald.com/article/908434491-alterity-therapeutics-receives-positive-fda-feedback-following-second-type-c-meeting-on-ath434-phase-3-program-in-multiple-system-atrophy Australian Healthcare Herald en PressRelease 2026-04-27T11:25:00+00:00 Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png